Download fulltext HTML
1.
Maleki A, Lagrew M, Slaney E. Bilateral Optic Neuropathy Secondary to Intravenous Carboplatin Therapy. JOVR [Internet]. 2024Mar.10 [cited 2024Apr.28];19(1):133–136. Available from: https://knepublishing.com/index.php/JOVR/article/view/15448

https://doi.org/10.18502/jovr.v19i1.15448

statistics

  • 196 Abstract Views
  • 122 PDF Views
  • 0 HTML Views

authors

  • Arash Maleki

    Arash Maleki

    Department of Ophthalmology, University of Florida, Gainesville, FL, USA
    https://orcid.org/0000-0001-5533-9798
  • Mollie Lagrew

    Mollie Lagrew

    Department of Ophthalmology, University of Florida, Gainesville, FL, USA
  • Elizabeth Slaney

    Elizabeth Slaney

    College of Medicine, University of Florida, Gainesville, FL, USA

Published Date

  • Mar 10, 2024
This journal is publishing all the articles under Creative Commons Attribution License CC BY 4.0.

Bilateral Optic Neuropathy Secondary to Intravenous Carboplatin Therapy

Journal of Ophthalmic and Vision Research (JOVR) / Jan–Mar 2024, Volume 19, Issue 1 / Pages 133–136

Abstract

Purpose: To report a case of carboplatin-induced bilateral optic neuropathy in a patient with metastatic squamous cell carcinoma of the tongue.


Case Report: A 65-year-old man with a history of squamous cell carcinoma of the tongue with metastasis to the right axillary lymph node treated with carboplatin and paclitaxel was evaluated for decreased visual acuity in both eyes. Visual acuity was 20/70 in the right eye and no light perception in the left eye. On dilated fundus examination, optic disc edema was present in both eyes with more severity in the left eye, flame shape hemorrhages around the optic nerve head in both eyes and cotton wool spots around the left optic nerve head. Brain and orbital MRI demonstrated enhancement of the bilateral optic nerve sheaths. He was diagnosed with bilateral carboplatin-induced optic neuropathy.


Conclusion: Our findings in this case justify monitoring of patients during their course of intravenous carboplatin therapy.

Keywords:

Carboplatin, Chemotherapy-induced Optic Neuropathy, Disc Edema, Optic Neuropathy, Papilledema

References
1. Rankin EM, Pitts JF. Ophthalmic toxicity during carboplatin therapy. Ann Oncol 1993;4:337–338.

2. Lauer AK, Wobig JL, Shults WT, Neuwelt EA, Wilson MW. Severe ocular and orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy. Am J Ophthalmol 1999;127:230–233.

3. Caraceni A, Martini C, Spatti G, Thomas A, Onofrj M. Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy. Acta Neurol Scand 1997;96:260–261.

4. Fischer N, Stuermer J, Rodic B, Pless M. Carboplatininduced bilateral papilledema: A case report. Case Rep Oncol 2009;2:67–71.

5. Lewis P, Waqar S, Yiannakis D, Raman V. Unilateral optic disc papilloedema following administration of carboplatin chemotherapy for ovarian carcinoma. Case Rep Oncol 2014;7:29–32.

6. Scaioli V, Caraceni A, Martini C, Palazzini E, Tarenzi E, Fulfaro F, Munzone E. Visual evoked potentials findings in course of paclitaxel doxorubicin combination chemotherapy. Report of a case. J Neurooncol 1995;25:221–225.

7. Li Y, Li Y, Li J, Pi G, Tan W. Paclitaxel- and/or cisplatin-induced ocular neurotoxicity: A case report and literature review. Onco Targets Ther 2014;7:1361–1366.

8. Capri G, Munzone E, Tarenzi E, Fulfaro F, Gianni L, Caraceni A, Martini C, Scaioli V. Optic nerve disturbances: A new form of paclitaxel neurotoxicity. J Natl Cancer Inst 1994;86:1099–1101.